51. Immunotherapy in non-small cell lung cancer harbouring driver mutations. (May 2021) Authors: Addeo, Alfredo; Passaro, Antonio; Malapelle, Umberto; Luigi Banna, Giuseppe; Subbiah, Vivek; Friedlaender, Alex Journal: Cancer treatment reviews Issue: Volume 96(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial. Issue 5 (May 2020) Authors: Trigo, José; Subbiah, Vivek; Besse, Benjamin; Moreno, Victor; López, Rafael; Sala, María Angeles; Peters, Solange; Ponce, Santiago; Fernández, Cristian; Alfaro, Vicente; Gómez, Javier; Kahatt, Carmen; Zeaiter, Ali; Zaman, Khalil; Boni, Valentina; Arrondeau, Jennifer; Martínez, Maite; Delord, Jean... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study. (September 2022) Authors: Longo-Muñoz, Federico; Castellano, Daniel; Alexandre, Jerome; Chawla, Sant P.; Fernández, Cristian; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Zeaiter, Ali; Moreno, Victor; Sanz-García, Enrique; Awada, Ahmad; Santaballa, Ana; Subbiah, Vivek Journal: European journal of cancer Issue: Volume 172(2022) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3′-deoxy-3′[(18)F]-fluorothymidine, [(18)F]-FLT imaging and early response evaluation. Issue 5 (6th May 2019) Authors: Kairemo, Kalevi; Subbiah, Vivek Journal: BMJ case reports Issue: Volume 12:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Issue 7 (3rd July 2018) Authors: Strati, Paolo; Tang, Guilin; Duose, Dzifa Y.; Mallampati, Saradhi; Luthra, Rajyalakshmi; Patel, Keyur P.; Hussaini, Mohammad; Mirza, Abu-Sayeef; Komrokji, Rami S.; Oh, Stephen; Mascarenhas, John; Najfeld, Vesna; Subbiah, Vivek; Kantarjian, Hagop; Garcia-Manero, Guillermo; Verstovsek, Srdan; Daver... Journal: Leukemia & lymphoma Issue: Volume 59:Issue 7(2018) Page Start: 1672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Issue 1 (9th November 2020) Authors: Jozaghi, Yelda; Zafereo, Mark; Williams, Michelle D.; Gule‐Monroe, Maria K.; Wang, Jennifer; Grubbs, Elizabeth G.; Vaporciyan, Ara; Hu, Mimi I.; Busaidy, Naifa; Dadu, Ramona; Waguespack, Steven G.; Subbiah, Vivek; Cabanillas, Maria Journal: Head & neck Issue: Volume 43:Issue 1(2021) Page Start: E7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings. (21st November 2022) Authors: Nelson, Blessie Elizabeth; Adashek, Jacob J.; Lin, Steven H.; Subbiah, Vivek Journal: Cancer medicine Issue: Volume 12:Number 6(2023) Page Start: 6451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Issue 1 (December 2017) Authors: Dembla, Vikas; Groisberg, Roman; Hess, Ken; Fu, Siqing; Wheler, Jennifer; Hong, David; Janku, Filip; Zinner, Ralph; Piha-Paul, Sarina; Ravi, Vinod; Benjamin, Robert; Patel, Shreyaskumar; Somaiah, Neeta; Herzog, Cynthia; Karp, Daniel; Roszik, Jason; Meric-Bernstam, Funda; Subbiah, Vivek Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Overview of Ocular Side Effects of Selinexor. (8th April 2021) Authors: Al-Zubidi, Nagham; Gombos, Dan S.; Hong, David S.; Subbiah, Vivek; Fu, Siqing; Ahnert, Jordi Rodon; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Karp, Daniel D.; Bernstam, Funda Meric; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Overview of Ocular Side Effects of Selinexor. (8th April 2021) Authors: Al‐Zubidi, Nagham; Gombos, Dan S.; Hong, David S.; Subbiah, Vivek; Fu, Siqing; Ahnert, Jordi Rodon; Piha‐Paul, Sarina A.; Tsimberidou, Apostolia M.; Karp, Daniel D.; Bernstam, Funda Meric; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗